Based on recent data, Aldeyra Therapeutics, Inc. (ALDX) shows an Average True Range (ATR) of N/A and an Enterprise Value of N/A. Its average trading volume over the past 3 months is N/A, indicating liquidity. These fundamental metrics provide insight into ALDX's underlying financial health and market activity.
| ATR | N/A |
| Enterprise Value | - |
| Avg Vol (3 Months) | - |
| Avg Vol (10 Days) | - |
Aldeyra Therapeutics, Inc. (ALDX) technical indicators as of April 4, 2026: the SMA 20 is N/A, SMA 50 at N/A, and SMA 200 at N/A. The RSI 14 value is N/A, suggesting its current momentum. These technical analysis signals help assess ALDX's price trends and potential future movements.
| SMA 20 | N/A |
| SMA 50 | N/A |
| SMA 200 | N/A |
| RSI 14 | N/A |
Aldeyra Therapeutics, Inc. (ALDX) stock performance overview as of April 4, 2026: The 52-week high is $6.18 (currently N/A below), and the 52-week low is $1.07 (currently N/A above). Over the past year, ALDX's performance is -0.63%, compared to the S&P 500's N/A change.
| 52-Week High | 6.18 |
| 52-Week High Chg | - |
| 52-Week Low | 1.07 |
| 52-Week Low Chg | - |
| S&P 500 52-Week Chg | N/A |
According to market data, Aldeyra Therapeutics, Inc. (ALDX) stock's recent performance metrics show that over the last month, ALDX is -9.52%, with a Year-to-Date (YTD) performance of -8.3%. Over the past year, the stock has seen a -0.63% change. These figures summarize ALDX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 1.87 | 5.74 | 5.93 | 5.93 | 6.18 | 5.93 |
| Low | 1.63 | 1.07 | 1.07 | 1.07 | 1.07 | 1.07 |
| Performance | +15.01% | -9.52% | -9.70% | -11.87% | -0.63% | -8.30% |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep